Skip to the page

Data / Crowdfunding / California / MED-X, INC.

MED-X, INC.: crowdfunding raise on DEALMAKER SECURITIES LLC, $4,998 to $4,999,998 (2024)

MED-X, INC., a corporation in Canoga Park, CA, filed a Form C with the SEC on September 27, 2024 to raise $4,998 to $4,999,998 in common stock through DEALMAKER SECURITIES LLC. The offering closed on May 27, 2025. In its most recent fiscal year it reported $1,894,784 in revenue and $6,478,496 in net income, with 17 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
medx-rx.com
Funding portal
DEALMAKER SECURITIES LLC
Address
8236 REMMET AVE., Canoga Park, CA 91304
Legal form
Corporation
Jurisdiction
NV
Incorporated
February 24, 2014
SEC CIK
0001620704

Offering terms

From the amendment filed September 27, 2024.

Security
Common Stock
Price
$3.00
Target
$4,998
Maximum
$4,999,998
Deadline
May 27, 2025
Portal compensation
The Company is offering securities under Regulation CF, through Intermediary. Intermediary will receive cash compensation equal to 8.5% of the value of the securities sold through Regulation CF, fixed fees of $32,500 and a monthly fee of $2,000.

Financials

From the Form C-U filed April 15, 2025.

Most recent fiscal yearPrior fiscal yearSource
Revenue$1,894,784$1,852,775sec.gov
Cost of goods sold$1,641,617$1,570,977sec.gov
Net income$6,478,496$7,338,431sec.gov
Taxes paid$0$0sec.gov
Total assets$1,345,328$2,102,959sec.gov
Cash$65,747$209,472sec.gov
Accounts receivable$50,105$65,373sec.gov
Short-term debt$520,291$548,331sec.gov
Long-term debt$0$0sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
April 15, 2025Progress update$4,998$4,999,998May 27, 2025As of April 4, 2025, Med-X, Inc. (the "Company") has opted to terminate its Regulation CF Offering. The Company raised $1,678,671 with 1,218 investments.sec.gov
September 27, 2024Amendment$4,998$4,999,998May 27, 2025Amendment to add 2023 Audited financials, and increase the raise limit to $5,000,000.sec.gov
July 10, 2024Amendment$4,998$4,999,998September 30, 2024Amendment to add 2023 Audited financials, and increase the raise limit to $5,000,000.sec.gov
May 28, 2024Offering$1,234,998$1,234,998September 30, 2024sec.gov
January 24, 2023WithdrawalNot listedNot listedsec.gov
January 23, 2023Amendment$10,000$3,000,000May 31, 2023Med-X, Inc. removed a reference to a potential public offering on their investment page. There is no public offering scheduled at this time and there may never be.sec.gov
January 19, 2023Offering$10,000$3,000,000May 31, 2023sec.gov
January 17, 2023Annual reportNot listedNot listedsec.gov
June 1, 2021Amendment$10,000$1,070,000September 10, 2021Extending offering deadline.sec.gov
March 1, 2021Amendment$10,000$1,070,000May 31, 2021Extending offering deadline.sec.gov
November 30, 2020Amendment$10,000$1,070,000February 26, 2021Extending offering deadline.sec.gov
November 2, 2020Amendment$10,000$1,070,000November 30, 2020Extending offering deadline.sec.gov
August 31, 2020Amendment$10,000$1,070,000October 31, 2020Extending offering deadline.sec.gov
July 31, 2020Amendment$10,000$1,070,000August 31, 2020Extending offering deadline.sec.gov
May 21, 2020Offering$10,000$1,070,000July 31, 2020sec.gov

All filings on sec.gov

Also on SpecStream

Updated April 15, 2025. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.